NCT05577767

Brief Summary

a monocentric study to evaluate the efficacy of a longitudinal nursing follow up in smoking cessation in patients screened for Chronic obstructive pulmonary disease (COPD).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
233

participants targeted

Target at P75+ for all trials

Timeline
4mo left

Started Sep 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Sep 2020Sep 2026

Study Start

First participant enrolled

September 11, 2020

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

October 10, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 11, 2026

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

6 years

First QC Date

October 10, 2022

Last Update Submit

March 17, 2026

Conditions

COPDNurse's Role

Outcome Measures

Primary Outcomes (1)

  • number of cigarettes or other toxic substances

    per day

    up to 1 year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Smoking patients screened for COPD between 35 years old 65 years old

You may qualify if:

  • Smoking patients screened for COPD between 35 years old 65 years old
  • Read, write and understand the French language
  • Patient affiliated to a social security system
  • Written and signed informed consent

You may not qualify if:

  • Patients with a diagnosis of respiratory diseases
  • Patients receiving inhaled respiratory therapy
  • Persons unable to perform spirometry
  • Pregnant women
  • Refusal to participate in research
  • Patient under guardianship, deprived of liberty, safeguard of justice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ch Valence

Valence, Drome, 26953, France

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gilles RIVAL, MD

    CH VALENCE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 10, 2022

First Posted

October 13, 2022

Study Start

September 11, 2020

Primary Completion (Estimated)

September 11, 2026

Study Completion (Estimated)

September 11, 2026

Last Updated

March 18, 2026

Record last verified: 2026-03

Locations

FR(1)